Article
Individualization of antiviral treatment regimens for chronic hepatitis C.
European journal of gastroenterology & hepatology - 1 Apr 2006
Paulon Emma, Naoumov Nikolai V
Abstract excerpt
The treatment of patients with chronic hepatitis C has rapidly evolved in the past 10 years. The introduction of ribavirin and, more recently, its combination with pegylated interferon represent two landmark changes in improving the treatment efficacy. Overall, sustained virological response at present can be expected in 43-46% of patients infected with genotype 1 and 75-80% in genotype 2 or 3 infection. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
